Ocalvia gets NHS green light for rare chronic liver disease
admin 27th April 2017 Uncategorised 0Intercept’s Ocaliva has been issued a final green light for use by the NHS to treat the rare chronic liver disease primary biliary cholangitis (PBC), which affects around one in 1,000 women over the age of 40 but is still the leading cause of liver transplantation in adult women in the UK.
More: Ocalvia gets NHS green light for rare chronic liver disease
Source: News